APO Research

APO RESEARCH · REPORT

In Vitro Biology Service

Selected research

Market Structure

Global In Vitro Biology Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global In Vitro Biology Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for In Vitro Biology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for In Vitro Biology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for In Vitro Biology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for In Vitro Biology Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of In Vitro Biology Service include Oncodesign Services, NuChem Sciences Inc, Jubilant Biosys, Pharmaron, Melior Discovery, NUVISAN GmbH, Dalriada, Pharmacelsu and Paraza Pharma, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global In Vitro Biology Service market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of In Vitro Biology Service and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents In Vitro Biology Service revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the In Vitro Biology Service market size, projected growth trends, production technologies, key applications, and end-use industries.

In Vitro Biology Service Segment by Company

Oncodesign Services

NuChem Sciences Inc

Jubilant Biosys

Pharmaron

Melior Discovery

NUVISAN GmbH

Dalriada

Pharmacelsu

Paraza Pharma, Inc

PORSOLT

Sygnature Discovery

Aurigene Pharmaceutical Services Ltd

Charles River Laboratories

HitGen Inc

Piramal Pharma Solutions

GenScript ProBio

Ichor Life Sciences, Inc

LAXAI Life Sciences Pvt. Ltd

ChemPartner

In Vitro Biology Service Segment by Type

Assay Development Services

High-throughput Screening Services

Mechanism of Action Research Services

Others

In Vitro Biology Service Segment by Application

Pharmaceutical Research and Development

Biotechnology

Disease Research

Others

In Vitro Biology Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In Vitro Biology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of In Vitro Biology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In Vitro Biology Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of In Vitro Biology Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global In Vitro Biology Service industry.

Chapter 3: Detailed analysis of In Vitro Biology Service companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, In Vitro Biology Servicerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global In Vitro Biology Service Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Assay Development Services Table 3. Key Players of High-throughput Screening Services Table 4. Key Players of Mechanism of Action Research Services Table 3. Key Players of Others Table 4. Global In Vitro Biology Service Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Pharmaceutical Research and Development Table 6. Key Players of Biotechnology Table 7. Key Players of Disease Research Table 8. Key Players of Others Table 9. Global In Vitro Biology Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global In Vitro Biology Service Market Size by Region (2021-2026) & (US$ Million) Table 11. Global In Vitro Biology Service Market Share by Region (2021-2026) Table 12. Global In Vitro Biology Service Market Size by Region (2027-2032) & (US$ Million) Table 13. Global In Vitro Biology Service Market Share by Region (2027-2032) Table 14. In Vitro Biology Service Industry Trends Table 15. In Vitro Biology Service Industry Drivers Table 16. In Vitro Biology Service Industry Opportunities and Challenges Table 17. In Vitro Biology Service Industry Restraints Table 18. Global In Vitro Biology Service Revenue by Company (US$ Million) & (2021-2026) Table 19. Global In Vitro Biology Service Revenue Market Share by Company (2021-2026) Table 20. Global In Vitro Biology Service Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global In Vitro Biology Service Key Company Head Office and Area Served Table 22. Global In Vitro Biology Service Company, Product Type & Application Table 23. Global In Vitro Biology Service Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global In Vitro Biology Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global In Vitro Biology Service Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global In Vitro Biology Service Market Size by Type (2021-2026) & (US$ Million) Table 28. Global In Vitro Biology Service Market Size by Type (2027-2032) & (US$ Million) Table 29. Global In Vitro Biology Service Revenue Market Share by Type (2021-2026) Table 30. Global In Vitro Biology Service Revenue Market Share by Type (2027-2032) Table 31. Global In Vitro Biology Service Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global In Vitro Biology Service Market Size by Application (2021-2026) & (US$ Million) Table 33. Global In Vitro Biology Service Market Size by Application (2027-2032) & (US$ Million) Table 34. Global In Vitro Biology Service Revenue Market Share by Application (2021-2026) Table 35. Global In Vitro Biology Service Revenue Market Share by Application (2027-2032) Table 36. Oncodesign Services Company Information Table 37. Oncodesign Services Business Overview Table 38. Oncodesign Services In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Oncodesign Services In Vitro Biology Service Product Portfolio Table 40. Oncodesign Services Recent Development Table 41. NuChem Sciences Inc Company Information Table 42. NuChem Sciences Inc Business Overview Table 43. NuChem Sciences Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. NuChem Sciences Inc In Vitro Biology Service Product Portfolio Table 45. NuChem Sciences Inc Recent Development Table 46. Jubilant Biosys Company Information Table 47. Jubilant Biosys Business Overview Table 48. Jubilant Biosys In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Jubilant Biosys In Vitro Biology Service Product Portfolio Table 50. Jubilant Biosys Recent Development Table 51. Pharmaron Company Information Table 52. Pharmaron Business Overview Table 53. Pharmaron In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Pharmaron In Vitro Biology Service Product Portfolio Table 55. Pharmaron Recent Development Table 56. Melior Discovery Company Information Table 57. Melior Discovery Business Overview Table 58. Melior Discovery In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Melior Discovery In Vitro Biology Service Product Portfolio Table 60. Melior Discovery Recent Development Table 61. NUVISAN GmbH Company Information Table 62. NUVISAN GmbH Business Overview Table 63. NUVISAN GmbH In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. NUVISAN GmbH In Vitro Biology Service Product Portfolio Table 65. NUVISAN GmbH Recent Development Table 66. Dalriada Company Information Table 67. Dalriada Business Overview Table 68. Dalriada In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Dalriada In Vitro Biology Service Product Portfolio Table 70. Dalriada Recent Development Table 71. Pharmacelsu Company Information Table 72. Pharmacelsu Business Overview Table 73. Pharmacelsu In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Pharmacelsu In Vitro Biology Service Product Portfolio Table 75. Pharmacelsu Recent Development Table 76. Paraza Pharma, Inc Company Information Table 77. Paraza Pharma, Inc Business Overview Table 78. Paraza Pharma, Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Paraza Pharma, Inc In Vitro Biology Service Product Portfolio Table 80. Paraza Pharma, Inc Recent Development Table 81. PORSOLT Company Information Table 82. PORSOLT Business Overview Table 83. PORSOLT In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. PORSOLT In Vitro Biology Service Product Portfolio Table 85. PORSOLT Recent Development Table 86. Sygnature Discovery Company Information Table 87. Sygnature Discovery Business Overview Table 88. Sygnature Discovery In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Sygnature Discovery In Vitro Biology Service Product Portfolio Table 90. Sygnature Discovery Recent Development Table 91. Aurigene Pharmaceutical Services Ltd Company Information Table 92. Aurigene Pharmaceutical Services Ltd Business Overview Table 93. Aurigene Pharmaceutical Services Ltd In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. Aurigene Pharmaceutical Services Ltd In Vitro Biology Service Product Portfolio Table 95. Aurigene Pharmaceutical Services Ltd Recent Development Table 96. Charles River Laboratories Company Information Table 97. Charles River Laboratories Business Overview Table 98. Charles River Laboratories In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. Charles River Laboratories In Vitro Biology Service Product Portfolio Table 100. Charles River Laboratories Recent Development Table 101. HitGen Inc Company Information Table 102. HitGen Inc Business Overview Table 103. HitGen Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. HitGen Inc In Vitro Biology Service Product Portfolio Table 105. HitGen Inc Recent Development Table 106. Piramal Pharma Solutions Company Information Table 107. Piramal Pharma Solutions Business Overview Table 108. Piramal Pharma Solutions In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Piramal Pharma Solutions In Vitro Biology Service Product Portfolio Table 110. Piramal Pharma Solutions Recent Development Table 111. GenScript ProBio Company Information Table 112. GenScript ProBio Business Overview Table 113. GenScript ProBio In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. GenScript ProBio In Vitro Biology Service Product Portfolio Table 115. GenScript ProBio Recent Development Table 116. Ichor Life Sciences, Inc Company Information Table 117. Ichor Life Sciences, Inc Business Overview Table 118. Ichor Life Sciences, Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. Ichor Life Sciences, Inc In Vitro Biology Service Product Portfolio Table 120. Ichor Life Sciences, Inc Recent Development Table 121. LAXAI Life Sciences Pvt. Ltd Company Information Table 122. LAXAI Life Sciences Pvt. Ltd Business Overview Table 123. LAXAI Life Sciences Pvt. Ltd In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 124. LAXAI Life Sciences Pvt. Ltd In Vitro Biology Service Product Portfolio Table 125. LAXAI Life Sciences Pvt. Ltd Recent Development Table 126. ChemPartner Company Information Table 127. ChemPartner Business Overview Table 128. ChemPartner In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 129. ChemPartner In Vitro Biology Service Product Portfolio Table 130. ChemPartner Recent Development Table 131. North America In Vitro Biology Service Market Size by Type (2021-2026) & (US$ Million) Table 132. North America In Vitro Biology Service Market Size by Type (2027-2032) & (US$ Million) Table 133. North America In Vitro Biology Service Market Size by Application (2021-2026) & (US$ Million) Table 134. North America In Vitro Biology Service Market Size by Application (2027-2032) & (US$ Million) Table 135. North America In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. North America In Vitro Biology Service Market Size by Country (2021-2026) Table 137. North America In Vitro Biology Service Market Size by Country (2027-2032) Table 138. Europe In Vitro Biology Service Market Size by Type (2021-2026) & (US$ Million) Table 139. Europe In Vitro Biology Service Market Size by Type (2027-2032) & (US$ Million) Table 140. Europe In Vitro Biology Service Market Size by Application (2021-2026) & (US$ Million) Table 141. Europe In Vitro Biology Service Market Size by Application (2027-2032) & (US$ Million) Table 142. Europe In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Europe In Vitro Biology Service Market Size by Country (2021-2026) Table 144. Europe In Vitro Biology Service Market Size by Country (2027-2032) Table 145. China In Vitro Biology Service Market Size by Type (2021-2026) & (US$ Million) Table 146. China In Vitro Biology Service Market Size by Type (2027-2032) & (US$ Million) Table 147. China In Vitro Biology Service Market Size by Application (2021-2026) & (US$ Million) Table 148. China In Vitro Biology Service Market Size by Application (2027-2032) & (US$ Million) Table 149. Asia In Vitro Biology Service Market Size by Type (2021-2026) & (US$ Million) Table 150. Asia In Vitro Biology Service Market Size by Type (2027-2032) & (US$ Million) Table 151. Asia In Vitro Biology Service Market Size by Application (2021-2026) & (US$ Million) Table 152. Asia In Vitro Biology Service Market Size by Application (2027-2032) & (US$ Million) Table 153. Asia In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Asia In Vitro Biology Service Market Size by Country (2021-2026) Table 155. Asia In Vitro Biology Service Market Size by Country (2027-2032) Table 156. South America, Middle East & Africa In Vitro Biology Service Market Size by Type (2021-2026) & (US$ Million) Table 157. South America, Middle East & Africa In Vitro Biology Service Market Size by Type (2027-2032) & (US$ Million) Table 158. South America, Middle East & Africa In Vitro Biology Service Market Size by Application (2021-2026) & (US$ Million) Table 159. South America, Middle East & Africa In Vitro Biology Service Market Size by Application (2027-2032) & (US$ Million) Table 160. South America, Middle East & Africa In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 161. South America, Middle East & Africa In Vitro Biology Service Market Size by Country (2021-2026) Table 162. South America, Middle East & Africa In Vitro Biology Service Market Size by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. In Vitro Biology Service Product Image Figure 2. Global In Vitro Biology Service Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global In Vitro Biology Service Market Share by Type: 2025 VS 2032 Figure 4. Assay Development Services Image Figure 5. High-throughput Screening Services Image Figure 6. Mechanism of Action Research Services Image Figure 7. Others Image Figure 8. Global In Vitro Biology Service Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global In Vitro Biology Service Market Share by Application: 2025 VS 2032 Figure 10. Pharmaceutical Research and Development Image Figure 11. Biotechnology Image Figure 12. Disease Research Image Figure 13. Others Image Figure 14. Global In Vitro Biology Service Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 16. Global In Vitro Biology Service Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global In Vitro Biology Service Market Share by Players in 2025 Figure 19. Global Top 5 and 10 In Vitro Biology Service Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global In Vitro Biology Service Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global In Vitro Biology Service Revenue Market Share by Type (2021-2032) Figure 23. Global In Vitro Biology Service Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global In Vitro Biology Service Revenue Market Share by Application (2021-2032) Figure 25. North America In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 26. North America In Vitro Biology Service Market Share by Type (2021-2032) Figure 27. North America In Vitro Biology Service Market Share by Application (2021-2032) Figure 28. North America In Vitro Biology Service Market Share by Country (2021-2032) Figure 29. United States In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 30. Canada In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 31. Mexico In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 32. Europe In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 33. Europe In Vitro Biology Service Market Share by Type (2021-2032) Figure 34. Europe In Vitro Biology Service Market Share by Application (2021-2032) Figure 35. Europe In Vitro Biology Service Market Share by Country (2021-2032) Figure 36. Germany In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 37. France In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 38. U.K. In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 39. Italy In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 40. Russia In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 42. China In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 43. China In Vitro Biology Service Market Share by Type (2021-2032) Figure 44. China In Vitro Biology Service Market Share by Application (2021-2032) Figure 45. Asia In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 46. Asia In Vitro Biology Service Market Share by Type (2021-2032) Figure 47. Asia In Vitro Biology Service Market Share by Application (2021-2032) Figure 48. Asia In Vitro Biology Service Market Share by Country (2021-2032) Figure 49. Japan In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 50. South Korea In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 53. India In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 54. Australia In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa In Vitro Biology Service Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa In Vitro Biology Service Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa In Vitro Biology Service Market Share by Country (2021-2032) Figure 59. Brazil In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 60. South Africa In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 62. Turkey In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 63. Argentina In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 64. UAE In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 65. Egypt In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 66. Chile In Vitro Biology Service Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Assay Development Services
  • High-throughput Screening Services
  • Mechanism of Action Research Services
  • Others
Applications
  • Pharmaceutical Research and Development
  • Biotechnology
  • Disease Research
  • Others
Companies covered
  • Oncodesign Services
  • NuChem Sciences Inc
  • Jubilant Biosys
  • Pharmaron
  • Melior Discovery
  • NUVISAN GmbH
  • Dalriada
  • Pharmacelsu
  • Paraza Pharma, Inc
  • PORSOLT
  • Sygnature Discovery
  • Aurigene Pharmaceutical Services Ltd
  • Charles River Laboratories
  • HitGen Inc
  • Piramal Pharma Solutions
  • GenScript ProBio
  • Ichor Life Sciences, Inc
  • LAXAI Life Sciences Pvt. Ltd
  • ChemPartner

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global In Vitro Biology Service Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Assay Development Services
  5. 1.2.3 High-throughput Screening Services
  6. 1.2.4 Mechanism of Action Research Services
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global In Vitro Biology Service Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical Research and Development
  11. 1.3.3 Biotechnology
  12. 1.3.4 Disease Research
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global In Vitro Biology Service Growth Trends by Region
  16. 1.5.1 Global In Vitro Biology Service Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 In Vitro Biology Service Market Size by Region (2021-2026)
  18. 1.5.3 In Vitro Biology Service Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global In Vitro Biology Service Market Dynamics
  1. 2.1 In Vitro Biology Service Industry Trends
  2. 2.2 In Vitro Biology Service Industry Drivers
  3. 2.3 In Vitro Biology Service Industry Opportunities and Challenges
  4. 2.4 In Vitro Biology Service Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global In Vitro Biology Service Revenue by Company (2021-2026)
  2. 3.2 Global In Vitro Biology Service Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global In Vitro Biology Service Key Company Head office and Area Served
  4. 3.4 Global In Vitro Biology Service Company, Product Type & Application
  5. 3.5 Global In Vitro Biology Service Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global In Vitro Biology Service Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 In Vitro Biology Service Players Market Share by Revenue in 2025
  9. 3.6.3 2025 In Vitro Biology Service Tier 1, Tier 2, and Tier 3
4 In Vitro Biology Service Market by Type
  1. 4.1 Global In Vitro Biology Service Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global In Vitro Biology Service Market Size by Type (2021-2032)
  3. 4.3 Global In Vitro Biology Service Market Size Share by Type (2021-2032)
5 In Vitro Biology Service Market by Application
  1. 5.1 Global In Vitro Biology Service Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global In Vitro Biology Service Market Size by Application (2021-2032)
  3. 5.3 Global In Vitro Biology Service Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Oncodesign Services
  2. 6.1.1 Oncodesign Services Company Information
  3. 6.1.2 Oncodesign Services Business Overview
  4. 6.1.3 Oncodesign Services In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Oncodesign Services In Vitro Biology Service Product Portfolio
  6. 6.1.5 Oncodesign Services Recent Developments
  7. 6.2 NuChem Sciences Inc
  8. 6.2.1 NuChem Sciences Inc Company Information
  9. 6.2.2 NuChem Sciences Inc Business Overview
  10. 6.2.3 NuChem Sciences Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 NuChem Sciences Inc In Vitro Biology Service Product Portfolio
  12. 6.2.5 NuChem Sciences Inc Recent Developments
  13. 6.3 Jubilant Biosys
  14. 6.3.1 Jubilant Biosys Company Information
  15. 6.3.2 Jubilant Biosys Business Overview
  16. 6.3.3 Jubilant Biosys In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Jubilant Biosys In Vitro Biology Service Product Portfolio
  18. 6.3.5 Jubilant Biosys Recent Developments
  19. 6.4 Pharmaron
  20. 6.4.1 Pharmaron Company Information
  21. 6.4.2 Pharmaron Business Overview
  22. 6.4.3 Pharmaron In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Pharmaron In Vitro Biology Service Product Portfolio
  24. 6.4.5 Pharmaron Recent Developments
  25. 6.5 Melior Discovery
  26. 6.5.1 Melior Discovery Company Information
  27. 6.5.2 Melior Discovery Business Overview
  28. 6.5.3 Melior Discovery In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Melior Discovery In Vitro Biology Service Product Portfolio
  30. 6.5.5 Melior Discovery Recent Developments
  31. 6.6 NUVISAN GmbH
  32. 6.6.1 NUVISAN GmbH Company Information
  33. 6.6.2 NUVISAN GmbH Business Overview
  34. 6.6.3 NUVISAN GmbH In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 NUVISAN GmbH In Vitro Biology Service Product Portfolio
  36. 6.6.5 NUVISAN GmbH Recent Developments
  37. 6.7 Dalriada
  38. 6.7.1 Dalriada Company Information
  39. 6.7.2 Dalriada Business Overview
  40. 6.7.3 Dalriada In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Dalriada In Vitro Biology Service Product Portfolio
  42. 6.7.5 Dalriada Recent Developments
  43. 6.8 Pharmacelsu
  44. 6.8.1 Pharmacelsu Company Information
  45. 6.8.2 Pharmacelsu Business Overview
  46. 6.8.3 Pharmacelsu In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Pharmacelsu In Vitro Biology Service Product Portfolio
  48. 6.8.5 Pharmacelsu Recent Developments
  49. 6.9 Paraza Pharma, Inc
  50. 6.9.1 Paraza Pharma, Inc Company Information
  51. 6.9.2 Paraza Pharma, Inc Business Overview
  52. 6.9.3 Paraza Pharma, Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Paraza Pharma, Inc In Vitro Biology Service Product Portfolio
  54. 6.9.5 Paraza Pharma, Inc Recent Developments
  55. 6.10 PORSOLT
  56. 6.10.1 PORSOLT Company Information
  57. 6.10.2 PORSOLT Business Overview
  58. 6.10.3 PORSOLT In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 PORSOLT In Vitro Biology Service Product Portfolio
  60. 6.10.5 PORSOLT Recent Developments
  61. 6.11 Sygnature Discovery
  62. 6.11.1 Sygnature Discovery Company Information
  63. 6.11.2 Sygnature Discovery Business Overview
  64. 6.11.3 Sygnature Discovery In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sygnature Discovery In Vitro Biology Service Product Portfolio
  66. 6.11.5 Sygnature Discovery Recent Developments
  67. 6.12 Aurigene Pharmaceutical Services Ltd
  68. 6.12.1 Aurigene Pharmaceutical Services Ltd Company Information
  69. 6.12.2 Aurigene Pharmaceutical Services Ltd Business Overview
  70. 6.12.3 Aurigene Pharmaceutical Services Ltd In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Aurigene Pharmaceutical Services Ltd In Vitro Biology Service Product Portfolio
  72. 6.12.5 Aurigene Pharmaceutical Services Ltd Recent Developments
  73. 6.13 Charles River Laboratories
  74. 6.13.1 Charles River Laboratories Company Information
  75. 6.13.2 Charles River Laboratories Business Overview
  76. 6.13.3 Charles River Laboratories In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Charles River Laboratories In Vitro Biology Service Product Portfolio
  78. 6.13.5 Charles River Laboratories Recent Developments
  79. 6.14 HitGen Inc
  80. 6.14.1 HitGen Inc Company Information
  81. 6.14.2 HitGen Inc Business Overview
  82. 6.14.3 HitGen Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 HitGen Inc In Vitro Biology Service Product Portfolio
  84. 6.14.5 HitGen Inc Recent Developments
  85. 6.15 Piramal Pharma Solutions
  86. 6.15.1 Piramal Pharma Solutions Company Information
  87. 6.15.2 Piramal Pharma Solutions Business Overview
  88. 6.15.3 Piramal Pharma Solutions In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Piramal Pharma Solutions In Vitro Biology Service Product Portfolio
  90. 6.15.5 Piramal Pharma Solutions Recent Developments
  91. 6.16 GenScript ProBio
  92. 6.16.1 GenScript ProBio Company Information
  93. 6.16.2 GenScript ProBio Business Overview
  94. 6.16.3 GenScript ProBio In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 GenScript ProBio In Vitro Biology Service Product Portfolio
  96. 6.16.5 GenScript ProBio Recent Developments
  97. 6.17 Ichor Life Sciences, Inc
  98. 6.17.1 Ichor Life Sciences, Inc Company Information
  99. 6.17.2 Ichor Life Sciences, Inc Business Overview
  100. 6.17.3 Ichor Life Sciences, Inc In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 Ichor Life Sciences, Inc In Vitro Biology Service Product Portfolio
  102. 6.17.5 Ichor Life Sciences, Inc Recent Developments
  103. 6.18 LAXAI Life Sciences Pvt. Ltd
  104. 6.18.1 LAXAI Life Sciences Pvt. Ltd Company Information
  105. 6.18.2 LAXAI Life Sciences Pvt. Ltd Business Overview
  106. 6.18.3 LAXAI Life Sciences Pvt. Ltd In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  107. 6.18.4 LAXAI Life Sciences Pvt. Ltd In Vitro Biology Service Product Portfolio
  108. 6.18.5 LAXAI Life Sciences Pvt. Ltd Recent Developments
  109. 6.19 ChemPartner
  110. 6.19.1 ChemPartner Company Information
  111. 6.19.2 ChemPartner Business Overview
  112. 6.19.3 ChemPartner In Vitro Biology Service Revenue and Gross Margin (US$ Million) & (2021-2026)
  113. 6.19.4 ChemPartner In Vitro Biology Service Product Portfolio
  114. 6.19.5 ChemPartner Recent Developments
7 North America
  1. 7.1 North America In Vitro Biology Service Market Size (2021-2032)
  2. 7.2 North America In Vitro Biology Service Market Size by Type
  3. 7.2.1 North America In Vitro Biology Service Market Size by Type (2021-2026)
  4. 7.2.2 North America In Vitro Biology Service Market Size by Type (2027-2032)
  5. 7.2.3 North America In Vitro Biology Service Market Share by Type (2021-2032)
  6. 7.3 North America In Vitro Biology Service Market Size by Application
  7. 7.3.1 North America In Vitro Biology Service Market Size by Application (2021-2026)
  8. 7.3.2 North America In Vitro Biology Service Market Size by Application (2027-2032)
  9. 7.3.3 North America In Vitro Biology Service Market Share by Application (2021-2032)
  10. 7.4 North America In Vitro Biology Service Market Size by Country
  11. 7.4.1 North America In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America In Vitro Biology Service Market Size by Country (2021-2026)
  13. 7.4.3 North America In Vitro Biology Service Market Size by Country (2027-2032)
  14. 7.4.4 North America In Vitro Biology Service Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe In Vitro Biology Service Market Size (2021-2032)
  2. 8.2 Europe In Vitro Biology Service Market Size by Type
  3. 8.2.1 Europe In Vitro Biology Service Market Size by Type (2021-2026)
  4. 8.2.2 Europe In Vitro Biology Service Market Size by Type (2027-2032)
  5. 8.2.3 Europe In Vitro Biology Service Market Share by Type (2021-2032)
  6. 8.3 Europe In Vitro Biology Service Market Size by Application
  7. 8.3.1 Europe In Vitro Biology Service Market Size by Application (2021-2026)
  8. 8.3.2 Europe In Vitro Biology Service Market Size by Application (2027-2032)
  9. 8.3.3 Europe In Vitro Biology Service Market Share by Application (2021-2032)
  10. 8.4 Europe In Vitro Biology Service Market Size by Country
  11. 8.4.1 Europe In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe In Vitro Biology Service Market Size by Country (2021-2026)
  13. 8.4.3 Europe In Vitro Biology Service Market Size by Country (2027-2032)
  14. 8.4.4 Europe In Vitro Biology Service Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China In Vitro Biology Service Market Size (2021-2032)
  2. 9.2 China In Vitro Biology Service Market Size by Type
  3. 9.2.1 China In Vitro Biology Service Market Size by Type (2021-2026)
  4. 9.2.2 China In Vitro Biology Service Market Size by Type (2027-2032)
  5. 9.2.3 China In Vitro Biology Service Market Share by Type (2021-2032)
  6. 9.3 China In Vitro Biology Service Market Size by Application
  7. 9.3.1 China In Vitro Biology Service Market Size by Application (2021-2026)
  8. 9.3.2 China In Vitro Biology Service Market Size by Application (2027-2032)
  9. 9.3.3 China In Vitro Biology Service Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia In Vitro Biology Service Market Size (2021-2032)
  2. 10.2 Asia In Vitro Biology Service Market Size by Type
  3. 10.2.1 Asia In Vitro Biology Service Market Size by Type (2021-2026)
  4. 10.2.2 Asia In Vitro Biology Service Market Size by Type (2027-2032)
  5. 10.2.3 Asia In Vitro Biology Service Market Share by Type (2021-2032)
  6. 10.3 Asia In Vitro Biology Service Market Size by Application
  7. 10.3.1 Asia In Vitro Biology Service Market Size by Application (2021-2026)
  8. 10.3.2 Asia In Vitro Biology Service Market Size by Application (2027-2032)
  9. 10.3.3 Asia In Vitro Biology Service Market Share by Application (2021-2032)
  10. 10.4 Asia In Vitro Biology Service Market Size by Country
  11. 10.4.1 Asia In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia In Vitro Biology Service Market Size by Country (2021-2026)
  13. 10.4.3 Asia In Vitro Biology Service Market Size by Country (2027-2032)
  14. 10.4.4 Asia In Vitro Biology Service Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa In Vitro Biology Service Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa In Vitro Biology Service Market Size by Type
  3. 11.2.1 South America, Middle East & Africa In Vitro Biology Service Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa In Vitro Biology Service Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa In Vitro Biology Service Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa In Vitro Biology Service Market Size by Application
  7. 11.3.1 South America, Middle East & Africa In Vitro Biology Service Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa In Vitro Biology Service Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa In Vitro Biology Service Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa In Vitro Biology Service Market Size by Country
  11. 11.4.1 South America, Middle East & Africa In Vitro Biology Service Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa In Vitro Biology Service Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa In Vitro Biology Service Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa In Vitro Biology Service Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research